Healthcare provider profile · identity verified

Kara Ellen Davis, MD

Internal Medicine · SOUTH HOLLAND, IL · NPI 1417991449

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	690	220
Amlodipine Besylate	Amlodipine Besylate	689	202
Hydrochlorothiazide	Hydrochlorothiazide	330	100
Losartan Potassium	Losartan Potassium	276	76
Metformin Hcl	Metformin Hcl	262	79
Pantoprazole Sodium	Pantoprazole Sodium	231	79
Levothyroxine Sodium	Levothyroxine Sodium	216	51
Gabapentin	Gabapentin	200	62
Lisinopril	Lisinopril	190	56
Metoprolol Succinate	Metoprolol Succinate	178	59
Alendronate Sodium	Alendronate Sodium	154	45
Jardiance	Empagliflozin	144	37
Tramadol Hcl	Tramadol Hcl	127	41
Alprazolam	Alprazolam	126	24
Fluticasone Propionate	Fluticasone Propionate	126	58
Furosemide	Furosemide	115	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	106	25
Potassium Chloride	Potassium Chloride	106	32
Ozempic	Semaglutide	103	24
Albuterol Sulfate Hfa	Albuterol Sulfate	102	45
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	101	27
Rosuvastatin Calcium	Rosuvastatin Calcium	96	35
Carvedilol	Carvedilol	93	32
Ibuprofen	Ibuprofen	92	28
Clopidogrel	Clopidogrel Bisulfate	86	27
Diclofenac Sodium	Diclofenac Sodium	86	32
Metoprolol Tartrate	Metoprolol Tartrate	86	26
Nifedipine Er	Nifedipine	79	18
Omeprazole	Omeprazole	79	23
Pravastatin Sodium	Pravastatin Sodium	75	26
Simvastatin	Simvastatin	72	22
Allopurinol	Allopurinol	65	23
Montelukast Sodium	Montelukast Sodium	64	19
Glimepiride	Glimepiride	62	21
Duloxetine Hcl	Duloxetine Hcl	61	21
Hydralazine Hcl	Hydralazine Hcl	60	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	18
Enalapril Maleate	Enalapril Maleate	59	15
Tizanidine Hcl	Tizanidine Hcl	54	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	52	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	18
Eliquis	Apixaban	50	15
Famotidine	Famotidine	48	17
Donepezil Hcl	Donepezil Hcl	45	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	45	15
Spironolactone	Spironolactone	44	18
Tamsulosin Hcl	Tamsulosin Hcl	42	17
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Sertraline Hcl	Sertraline Hcl	40	13
Finasteride	Finasteride	38	suppressed
Naproxen	Naproxen	38	18
Pregabalin	Pregabalin	38	suppressed
Lovastatin	Lovastatin	37	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	36	28
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	12
Lorazepam	Lorazepam	35	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	suppressed
Symbicort	Budesonide/Formoterol Fumarate	33	suppressed
Ezetimibe	Ezetimibe	32	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Atenolol	Atenolol	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	19
Trulicity	Dulaglutide	31	suppressed
Klor-Con M20	Potassium Chloride	27	11
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Glipizide	Glipizide	25	suppressed
Hydrocortisone	Hydrocortisone	25	16
Januvia	Sitagliptin Phosphate	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	15
Benazepril Hcl	Benazepril Hcl	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Prednisone	Prednisone	23	14
Clonidine Hcl	Clonidine Hcl	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	22	suppressed
Irbesartan	Irbesartan	20	suppressed
Trazodone Hcl	Trazodone Hcl	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	19	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Azithromycin	Azithromycin	17	17
Celecoxib	Celecoxib	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Baclofen	Baclofen	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Fluconazole	Fluconazole	16	13
Midodrine Hcl	Midodrine Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Nystop	Nystatin	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Verapamil Er	Verapamil Hcl	15	suppressed
Diazepam	Diazepam	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Linzess	Linaclotide	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Nystatin	Nystatin	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Omnipod 5 Dexg7g6 Pods (Gen 5)	Insulin Pump Cart,auto,bt,g6/7	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Buspirone Hcl	Buspirone Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Ibu	Ibuprofen	12	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error